Evidence map›Paper›PMID 19384205›Full record

ArticleCritical care medicine2009

Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors.

Elliott D Crouser, Guohong Shao, Mark W Julian, Jennifer E Macre, Gerald S Shadel, Susheela Tridandapani, Qin Huang, Mark D Wewers

Open access · greenAbstract read
In one paragraph

Article in Critical care medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 111 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Mechanisms of mitochondrial damage-associated molecular patterns associated with inflammatory response in cardiovascular diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  5. Efferocytosis in atherosclerosis.Nature reviews. Cardiology · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Mitochondria in health, disease, and aging.Physiological reviews · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. TheNeural regeneration research · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Elliott D CrouserDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Dorothy M Davis Heart and Lung Research Institute, The Ohio State University Medical Center, Columbus, OH, USA. elliott.crouser@osumc.edu
Guohong Shao
Mark W Julian
Jennifer E Macre
Gerald S Shadel
Susheela Tridandapani
Qin Huang
Mark D Wewers
The Ohio State University · US

Funding

Induction of Inflammation by Mitochondrial ProteinsR03AI062740 · NIAID · OHIO STATE UNIVERSITY · PI CROUSER, ELLIOTT D · 2005 to 2006
$148k
NIAID NIH HHS AI62740NIAID NIH HHS R03 AI062740
6 · The paper itself

Abstract

objectiveNecrotic cells evoke potent innate immune responses through unclear mechanisms. The mitochondrial fraction of the cell retains constituents of its bacterial ancestors, including N-formyl peptides, which are potentially immunogenic. Thus, we hypothesized that the mitochondrial fraction of the cell, particularly N-formyl peptides, contributes significantly to the activation of monocytes by necrotic cells.

designHuman peripheral blood monocytes were incubated with necrotic cell fractions and mitochondrial proteins to investigate their potential for immune cell activation.

settingUniversity Medical Center Research Laboratory. SUBJECTS: Healthy human adults served as blood donors. MEASUREMENTS AND MAIN

resultsHuman blood monocyte activation was measured after treatment with cytosolic, nuclear and mitochondrial fractions of necrotic HepG2 cells or necrotic HepG2 cells depleted of N-formyl peptides [Rho(0) cells]. The specific role of the high affinity formyl peptide receptor (FPR) was then tested using specific pharmacologic inhibitors and RNA silencing. The capacity of mitochondrial N-formyl peptides to activate monocytes was confirmed using a synthetic peptide conforming to the N-terminus of mitochondrial nicotinamide adenine dinucleotide subunit 6. The results demonstrated that mitochondrial cell fractions most potently activated monocytes, and interleukin (IL)-8 was selectively released at low-protein concentrations. Mitochondria from Rho(0) cells induced minimal monocyte IL-8 release, and specific pharmacologic inhibitors and RNA-silencing confirmed that FPR contributes significantly to monocyte IL-8 responses to both necrotic cells and mitochondrial proteins. N-formyl peptides alone did not induce monocyte IL-8 release; whereas, the combination of mitochondrial N-formyl peptides and mitochondrial transcription factor A (TFAM) dramatically increased IL-8 release from monocytes. Likewise, high mobility group box 1, the nuclear homolog of TFAM, did not induce monocyte IL-8 release unless combined with mitochondrial N-formyl peptides.

conclusionsInteractions between mitochondrial N-formyl peptides and FPR in the presence of other mitochondrial antigens (e.g., TFAM) contributes significantly to the activation of monocytes by necrotic cells.

Indexed as

Cells, CulturedDNA-Binding ProteinsDNA, MitochondrialHumansMitochondrial ProteinsMonocytesNecrosisReceptors, Formyl PeptideTranscription FactorsDNA-Binding ProteinsDNA, MitochondrialMitochondrial ProteinsReceptors, Formyl PeptideTFAM protein, humanTranscription Factors

Identifiers

PMID19384205
PMCPMC2743203
OpenAlexW1999213589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.